Bone Biologics BBLG Growth Metrics (2011-2026)

NASDAQ BBLG
$0.41 -0.02 (-4.37%)
As of: Oct 21, 2026 · 1:50 PM EDT
Reported Financials

Bone Biologics Quarterly Growth Metrics

Periods 58 quarters
Latest Jun 2026

Bone Biologics reported asset growth of -36.64% for the quarter ended Jun 2026. These growth metrics cover 58 quarters of results from Oct 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Growth Ratios
Assets Growth (1y)
209.70%2,028.93%8,462.80%127,409.71%9,826.85%27.26%11.32%34.71%-4.32%-56.00%-43.40%-58.11%-18.30%3.31%-17.65%119.27%56.20%50.11%-36.64%
Assets Growth (3y)
-77.27%-71.86%85.80%95.62%176.95%175.27%550.75%891.30%1,645.66%1,164.54%277.87%796.10%326.54%-16.68%-19.64%7.36%6.88%-11.97%-16.51%
Assets Growth (5y)
-71.44%-41.60%56.94%29.15%45.48%25.53%60.58%70.52%82.38%16.19%29.14%36.37%64.34%74.77%162.76%239.96%446.76%381.22%298.08%
Assets (QoQ)
-93.76%1,080.55%12,640.95%-8.71%-7.14%-8.09%63.34%-20.15%12.37%-34.72%-24.89%2.72%-16.83%27.32%-5.03%-18.11%121.44%-9.30%-8.73%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
37.10%8,070.57%122,804.96%149,847.93%12.93%6.43%28.48%-11.99%-59.85%-47.84%-66.72%-19.90%9.86%-14.91%184.75%69.61%60.42%-39.28%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-75.57%-88.63%91.18%100.04%213.89%192.66%578.39%1,265.22%1,118.52%256.62%706.96%918.66%-20.73%-22.12%6.78%6.14%-10.89%-16.83%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-71.08%-65.48%60.83%29.24%47.43%25.55%61.31%75.53%87.23%14.18%25.94%34.75%67.60%77.60%167.79%307.91%376.56%290.54%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-93.76%-23.97%197,747.21%-12.89%-6.19%-7.25%49.00%-17.91%13.24%-36.46%-32.03%6.64%-27.75%52.93%-6.77%-17.40%141.77%-8.91%-11.82%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-703.68%-284.57%-48.66%-572.57%43.38%-42.30%-944.03%-56.83%-908.90%-546.44%-3.45%3.45%75.34%77.61%32.93%28.95%48.78%-7.49%48.28%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
1.57%39.91%48.13%2.51%38.53%5.91%-87.13%-108.06%-258.06%-228.28%-152.27%-116.76%-12.10%-27.24%-93.49%-2.47%-8.42%-15.87%28.94%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
20.69%28.69%31.82%3.11%15.37%6.76%-15.93%-10.52%-40.36%-14.82%-8.55%-7.01%10.39%-3.81%-35.38%-43.94%-42.12%-53.47%-40.98%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-396.93%56.32%32.73%-360.67%58.17%-9.78%-393.52%30.80%-169.09%29.66%21.02%35.41%31.27%36.13%-136.56%31.58%50.45%-34.02%-13.82%
EBIT Growth (1y)
-74.73%-57.58%-123.07%-281.10%-102.39%-430.61%-179.51%-356.50%-547.74%-70.67%9.87%71.29%73.37%54.30%-34.05%-14.94%7.61%24.79%52.85%-8.02%
EBIT Growth (3y)
35.40%-36.93%28.10%16.61%11.60%-59.35%-66.74%-109.96%-184.00%-142.55%-77.78%-70.93%-51.71%-60.55%-50.03%-14.63%-16.81%16.29%17.11%35.70%
EBIT Growth (5y)
44.33%43.11%31.77%20.42%-17.48%-1.52%0.36%-23.47%-28.72%-48.17%1.31%5.35%-3.57%-25.84%-41.14%-25.02%-41.32%-37.45%-28.85%-28.36%
EBIT Margin Growth (1y)
21.18M
EBIT Margin (QoQ)
-14.41M32.20M5.58M-2.19M
EBIT (QoQ)
-28.16%0.90%-100.39%-49.73%31.94%-159.81%-5.56%-144.55%3.42%31.55%44.25%22.11%10.39%-17.46%-63.50%33.21%27.96%4.38%-2.49%
EBT Growth (1y)
-29.44%-29.25%61.18%-52.04%4.59%-139.40%-630.73%-379.50%-547.65%-70.62%9.90%71.30%73.86%55.25%-32.34%-12.75%6.68%28.26%55.36%-4.34%
EBT Growth (3y)
26.95%-28.20%50.71%17.97%20.21%-29.50%-34.31%-74.21%-99.98%-74.13%-36.73%-27.90%-17.33%-22.27%-105.77%-15.77%-16.47%18.18%18.96%36.63%
EBT Growth (5y)
36.32%34.48%48.15%25.82%-19.74%12.49%14.21%-23.47%-19.22%-53.80%4.64%5.35%2.97%-10.65%-23.64%-11.34%-14.30%-11.13%-8.59%-9.48%
EBT Margin Growth (1y)
21.19M
EBT Margin (QoQ)
-14.40M32.20M5.58M-2.19M
EBT (QoQ)
-13.93%-3.54%65.42%-272.68%28.51%-159.81%-5.56%-144.55%3.43%31.55%44.26%22.11%12.04%-17.18%-64.84%33.64%27.20%9.91%-2.57%
EPS (Basic) Growth (1y)
-29.44%-29.25%74.89%55.07%73.16%32.65%299.88%-245.58%-24.21%82.67%-131.37%97.63%95.04%51.65%82.97%75.61%67.01%97.39%90.32%67.56%
EPS (Basic) Growth (3y)
38.16%-28.87%62.32%48.28%47.70%15.10%34.43%-3.95%24.43%46.77%46.00%66.73%74.52%61.64%52.56%72.86%72.71%87.02%-26.10%82.55%
EPS (Basic) Growth (5y)
44.03%42.23%58.35%48.74%-15.65%40.10%15.37%22.75%39.83%24.23%49.29%59.18%61.18%44.80%53.00%63.48%62.86%71.42%69.60%71.84%
EPS (Basic) (QoQ)
-13.93%-3.54%77.63%-70.24%31.94%-159.81%166.40%-394.33%75.54%63.76%-20.21%77.76%48.81%-253.15%57.66%68.14%30.75%72.02%-56.89%
EPS (Diluted) Growth (1y)
-29.44%-29.25%60.83%-59.70%83.70%59.10%177.72%41.02%-24.23%82.67%-131.42%97.63%95.04%51.65%82.97%75.61%67.01%97.39%90.32%67.56%
EPS (Diluted) Growth (3y)
26.98%-28.20%50.56%21.15%55.75%28.14%31.23%12.01%36.00%54.92%54.27%71.83%78.42%67.52%65.36%84.94%72.71%87.01%-26.10%82.55%
EPS (Diluted) Growth (5y)
38.16%36.39%49.56%27.26%-15.69%39.53%15.39%23.75%39.83%31.64%50.57%63.08%64.88%50.05%57.47%66.95%66.39%74.14%72.48%74.52%
EPS (Diluted) (QoQ)
-13.93%-3.54%65.10%-287.93%88.37%-159.81%166.31%-394.43%75.51%63.76%-20.21%77.76%48.81%-253.15%57.66%68.14%30.75%72.02%-56.89%
FCF Margin Growth (1y)
-26.83M
FCF Margin (QoQ)
-60.60M37.20M-10.15M6.71M
Free Cash Flow Growth (1y)FCF Growth (1y)
-703.68%-284.57%-48.66%-572.57%43.38%-42.30%-944.03%-56.83%-908.90%-546.44%-3.45%3.45%75.34%77.61%32.93%28.95%48.78%-7.49%48.28%
Free Cash Flow Growth (3y)FCF Growth (3y)
1.57%39.91%48.13%2.51%38.53%5.91%-87.13%-108.06%-258.06%-228.28%-152.27%-116.76%-12.10%-27.24%-93.49%-2.47%-8.42%-15.87%28.94%
Free Cash Flow Growth (5y)FCF Growth (5y)
20.69%28.69%31.82%3.11%15.37%6.76%-15.93%-10.52%-40.36%-14.82%-8.55%-7.01%10.39%-3.81%-35.38%-43.94%-42.12%-53.47%-40.98%
Free Cash Flow (QoQ)FCF (QoQ)
-396.93%56.32%32.73%-360.67%58.17%-9.78%-393.52%30.80%-169.09%29.66%21.02%35.41%31.27%36.13%-136.56%31.58%50.45%-34.02%-13.82%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
Net Cash Flow Growth (1y)NCF Growth (1y)
-2,643.71%-143.23%271,208.94%-1,309.55%-439.61%-37,050.28%-129.24%-56.83%-908.90%-546.44%26.90%114.89%75.35%148.31%83.08%-387.76%534.80%-149.82%-190.10%
Net Cash Flow Growth (3y)NCF Growth (3y)
0.06%-26.00%91.15%-55.49%13.17%-159.74%-122.25%-296.16%-1,043.11%-913.25%-733.69%41.37%-137.65%951.35%-26.75%12.40%134.01%-15.87%28.94%
Net Cash Flow Growth (5y)NCF Growth (5y)
49.48%76.57%151.35%-23.45%15.37%-19.83%-15.93%-33.46%-122.35%-26.85%-1.27%23.54%-10.24%117.33%-6.31%-92.81%337.52%-202.17%-209.60%
Net Cash Flow (QoQ)NCF (QoQ)
-193.76%98.41%627,166.82%-112.90%58.17%-9.78%-393.52%30.80%-169.09%29.66%44.19%114.10%-545.41%237.83%-119.55%-139.78%773.02%-115.79%-13.82%
Net Income Growth (1y)
-29.44%-29.25%60.83%-59.70%4.59%-139.40%602.69%-438.06%-276.99%-57.45%-273.47%76.66%55.70%50.98%1.82%-17.45%5.51%29.15%55.01%-4.48%
Net Income Growth (3y)
26.98%-28.20%50.56%21.15%20.26%-29.50%54.42%-83.86%-66.98%-69.52%-50.61%-26.11%-16.80%-22.71%-104.57%-13.83%-16.42%18.23%-40.38%24.10%
Net Income Growth (5y)
36.32%34.49%48.05%25.09%-19.74%12.49%18.36%-20.59%-6.97%-51.35%-1.05%9.25%3.27%-10.88%-23.43%-11.25%-14.27%-11.09%-8.58%-9.48%
Net Income (QoQ)
-13.93%-3.54%65.10%-287.93%31.94%-159.81%173.28%-515.23%52.31%-8.50%19.26%44.13%9.50%-20.07%-61.71%33.16%27.19%9.96%-2.69%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-29.44%-29.25%60.83%-59.70%4.59%-139.40%602.69%-438.06%-276.99%-57.45%-273.47%76.66%55.70%-116.36%1.82%-17.45%5.51%83.95%55.01%-4.48%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
26.98%-28.20%50.56%21.15%20.26%-29.50%54.42%-83.86%-66.98%-69.52%-50.61%-26.11%-16.80%-101.29%-104.57%-13.83%-16.42%18.23%-40.38%24.10%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
36.32%34.49%48.05%25.09%-19.74%12.49%18.36%-20.59%-6.97%-51.35%-1.05%9.25%3.27%-49.22%-23.43%-11.25%-14.27%-11.09%-8.58%-9.48%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-13.93%-3.54%65.10%-287.93%31.94%-159.81%173.28%-515.23%52.31%-8.50%19.26%44.13%9.50%-429.96%63.36%33.16%27.19%9.96%-2.69%
Net Margin Growth (1y)
32.77M
Net Margin (QoQ)
25.39M5.52M-8.59M10.45M
Operating Income Growth (1y)Op. Inc Growth (1y)
-74.73%-57.58%-123.07%-281.10%-102.39%-430.61%-179.51%-356.50%-547.74%-70.67%9.87%71.29%73.37%54.30%-34.05%-14.94%7.61%24.79%52.85%-8.02%
Operating Income Growth (3y)Op. Inc Growth (3y)
35.40%-36.93%28.10%16.61%11.60%-59.35%-66.74%-109.96%-184.00%-142.55%-77.78%-70.93%-51.71%-60.55%-50.03%-14.63%-16.81%16.29%17.11%35.70%
Operating Income Growth (5y)Op. Inc Growth (5y)
44.33%43.11%31.77%20.42%-17.48%-1.52%0.36%-23.47%-28.72%-48.17%1.31%5.35%-3.57%-25.84%-41.14%-25.02%-41.32%-37.45%-28.85%-28.36%
Operating Income (QoQ)Op. Inc (QoQ)
-28.16%0.90%-100.39%-49.73%31.94%-159.81%-5.56%-144.55%3.42%31.55%44.25%22.11%10.39%-17.46%-63.50%33.21%27.96%4.38%-2.49%
Operating Margin Growth (1y)
21.18M
Operating Margin (QoQ)
-14.41M32.20M5.58M-2.19M
Profit After Tax Growth (1y)PAT Growth (1y)
-29.44%-29.25%61.18%-59.70%10.99%-139.40%-630.73%-356.50%-594.21%-70.62%9.90%71.30%73.86%55.25%-32.34%-12.75%6.68%28.26%55.36%-4.34%
Profit After Tax Growth (3y)PAT Growth (3y)
26.98%-28.20%50.71%16.61%22.08%-29.50%-34.32%-74.06%-99.98%-74.13%-36.73%-27.90%-17.33%-22.27%-105.77%-13.89%-19.19%18.18%18.96%36.63%
Profit After Tax Growth (5y)PAT Growth (5y)
36.32%34.49%48.15%25.09%-19.44%12.49%14.21%-23.47%-19.19%-53.80%4.64%5.35%3.01%-10.65%-23.64%-11.28%-14.30%-11.13%-8.59%-9.48%
Profit After Tax (QoQ)PAT (QoQ)
-13.93%-3.54%65.42%-291.46%36.50%-178.48%-5.56%-144.55%3.43%31.55%44.26%22.11%12.04%-17.18%-64.84%33.64%27.20%9.91%-2.57%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
4.46M9.11M0.47M0.66M-523.00-0.01M-0.01M-0.01M-0.02M-0.01M0.00M0.00M0.01M0.01M0.01M0.00M0.01M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.29M-0.62M0.02M0.04M0.07M0.16M0.22M1.38M4.92M9.75M0.45M0.65M-0.01M-0.01M-0.01M0.00M181.000.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.38M-0.48M0.35M0.14M0.08M0.07M0.05M0.07M0.16M0.02M0.00M0.03M0.06M0.15M0.22M1.37M4.92M9.76M0.46M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-0.20M0.66M0.00M-161.000.00M-660.000.00M0.00M0.00M-0.01M0.00M0.00M0.00M-67.000.00M0.00M0.00M809.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.01M-0.02M0.00M0.00M0.01M0.01M0.01M0.01M0.00M0.01M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.01M0.00M0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.09M0.62M0.02M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.01M390.000.00M-0.01M0.01M0.00M0.00M-372.000.00M0.00M0.00M676.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.01M-0.02M-0.02M-0.02M-0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.01M-0.01M0.00M0.00M0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-158.000.00M0.00M-0.01M-0.01M395.00-0.01M0.01M0.01M0.00M-138.000.00M0.00M0.00M819.00
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y)
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
21.18M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-14.41M32.20M5.58M-2.19M
Revenue Growth (1y)
-54.14%
Revenue (QoQ)
-23.02%25.23%-34.89%-26.93%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
-70.71%-11.08%-38.45%13.81%17.69%4.64%-10.41%41.63%-3.94%317.93%385.93%-54.67%-88.68%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
81.12%11.44%64.61%106.47%-30.82%57.25%38.90%-9.93%-20.89%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-21.35%-48.75%-38.41%-21.50%-25.56%-38.90%-27.67%24.39%15.42%5.18%19.72%66.94%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-87.73%73.53%92.13%-28.39%-62.76%20.13%255.23%-25.95%-66.89%2.86%461.59%-49.77%44.05%19.59%-47.61%
Total Debt Growth (1y)
8.39%10.07%
Total Debt Growth (3y)
10.88%12.36%
Total Debt Growth (5y)
-3.13%-3.12%
Total Debt (QoQ)
4.77%2.22%

Bone Biologics Growth Metrics API

Pull Bone Biologics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BBLG&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY